A round of Series A venture capital financing has brought in approximately $7.6 million for Evasc Neurovascular Enterprises, a Canadian medical device company that develops endovascular treatments for cerebral aneurysms. The proceeds will be used to support product development and commercialization.
Canadian medtech company obtains $7.6M in funding round
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.